日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Evaluation of ABT-888 in the amelioration of α-synuclein fibril-induced neurodegeneration.

评价 ABT-888 对 α-突触核蛋白原纤维诱导的神经退行性变的改善作用

Hastings Lyndsay, Sokratian Arpine, Apicco Daniel J, Stanhope Christina M, Smith Lindsey, Hirst Warren D, West Andrew B, Kelly Kaela

Pharmacodynamic Biomarkers for Emerging LRRK2 Therapeutics

新兴LRRK2疗法的药效学生物标志物

Kelly, Kaela; West, Andrew B